BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28034727)

  • 1. Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implications.
    Lee LH; Yantiss RK; Sadot E; Ren B; Calvacanti MS; Hechtman JF; Ivelja S; Huynh B; Xue Y; Shitilbans T; Guend H; Stadler ZK; Weiser MR; Vakiani E; Gönen M; Klimstra DS; Shia J
    Hum Pathol; 2017 Apr; 62():74-82. PubMed ID: 28034727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics.
    Rüschoff J; Dietmaier W; Lüttges J; Seitz G; Bocker T; Zirngibl H; Schlegel J; Schackert HK; Jauch KW; Hofstaedter F
    Am J Pathol; 1997 May; 150(5):1815-25. PubMed ID: 9137104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
    Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
    Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival.
    Lanza G; Gafà R; Matteuzzi M; Santini A
    J Clin Oncol; 1999 Aug; 17(8):2429-38. PubMed ID: 10561306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Grade Is Prognostically Relevant Among Mismatch Repair Deficient Colorectal Carcinomas.
    Johncilla M; Chen Z; Sweeney J; Yantiss RK
    Am J Surg Pathol; 2018 Dec; 42(12):1686-1692. PubMed ID: 30179899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
    Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
    Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens.
    O'Brien O; Ryan É; Creavin B; Kelly ME; Mohan HM; Geraghty R; Winter DC; Sheahan K
    J Clin Pathol; 2018 Jul; 71(7):631-636. PubMed ID: 29419411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases.
    Knox RD; Luey N; Sioson L; Kedziora A; Clarkson A; Watson N; Toon CW; Cussigh C; Pincott S; Pillinger S; Salama Y; Evans J; Percy J; Schnitzler M; Engel A; Gill AJ
    Ann Surg Oncol; 2015 Sep; 22(9):2988-96. PubMed ID: 25572685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.
    Wang J; Andrici J; Sioson L; Clarkson A; Sheen A; Farzin M; Toon CW; Turchini J; Gill AJ
    Hum Pathol; 2016 Sep; 55():83-90. PubMed ID: 27184481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.
    Sirohi D; Smith SC; Ohe C; Colombo P; Divatia M; Dragoescu E; Rao P; Hirsch MS; Chen YB; Mehra R; Amin MB
    Hum Pathol; 2017 Sep; 67():134-145. PubMed ID: 28716439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum.
    Takahashi S; Kohashi K; Yamamoto H; Hirahashi M; Kumagai R; Takizawa N; Nakamura K; Maehara Y; Tanaka M; Takayanagi R; Oda Y
    Hum Pathol; 2015 Sep; 46(9):1257-66. PubMed ID: 26208847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin 20 - a diagnostic and prognostic marker in colorectal cancer?
    Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Rehak P; Langner C
    Histol Histopathol; 2012 Mar; 27(3):347-56. PubMed ID: 22237712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.
    Graham RP; Vierkant RA; Tillmans LS; Wang AH; Laird PW; Weisenberger DJ; Lynch CF; French AJ; Slager SL; Raissian Y; Garcia JJ; Kerr SE; Lee HE; Thibodeau SN; Cerhan JR; Limburg PJ; Smyrk TC
    Am J Surg Pathol; 2015 Oct; 39(10):1340-6. PubMed ID: 26200097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital.
    Scott N; West NP; Cairns A; Rotimi O
    Histopathology; 2021 Jun; 78(7):963-969. PubMed ID: 33247957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of molecular-pathologic entities of colorectal cancer].
    Kirchner T; Reu S
    Pathologe; 2008 Nov; 29 Suppl 2():264-9. PubMed ID: 18841367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
    Pyo JS; Sohn JH; Kang G
    Hum Pathol; 2016 Jul; 53():91-6. PubMed ID: 27001432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should the grading of colorectal adenocarcinoma include microsatellite instability status?
    Rosty C; Williamson EJ; Clendenning M; Walters RJ; Win AK; Jenkins MA; Hopper JL; Winship IM; Southey MC; Giles GG; English DR; Buchanan DD
    Hum Pathol; 2014 Oct; 45(10):2077-84. PubMed ID: 25149551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.
    Baloch ZW; LiVolsi VA
    Turk Patoloji Derg; 2015; 31 Suppl 1():60-79. PubMed ID: 26177318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.